Literature DB >> 18383148

Percutaneous revascularization of subclavian artery chronic occlusion with dual cerebral artery protection.

Nehal Shah1, Lisa M Nee, Amish N Raval.   

Abstract

Percutaneous intervention for symptomatic subclavian artery chronic occlusion is an occasionally performed, minimally invasive alternative to surgical bypass. Potential complications include stroke, perforation, and recanalization failure. We discuss a case of successful percutaneous revascularization of symptomatic subclavian artery chronic occlusion using coronary devices and dual cerebral embolic protection. 2008 Wiley-Liss, Inc.

Entities:  

Mesh：

Year:  2008        PMID： 18383148     DOI： 10.1002/ccd.21520

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


  4 in total

1.  Landmark-wire technique of symptomatic subclavian artery occlusion.

Authors:  S Liu; J Hee Jung; H-Ju Kwon; S-Mi Kim; D C Suh
Journal:  Interv Neuroradiol       Date:  2009-12-28       Impact factor: 1.610

2.  Endovascular Stenting under Cardiac and Cerebral Protection for Subclavian Steal after Coronary Artery Bypass Grafting Due to Right Subclavian Artery Origin Stenosis.

Authors:  Shigeyuki Sakamoto; Yoshihiro Kiura; Takahito Okazaki; Nobuhiko Ichinose; Kaoru Kurisu
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2015-03-31

3.  The Use of Protection Device in Landmark-wire Technique of Symptomatic Subclavian Artery Occlusion with Combined Approach via Trans-femoral vs. Trans-brachial Arteries: Technical note.

Authors:  Soonchan Park; Jae Hyuk Kwak; Hye Jin Baek; Jee Won Park; Jong Sung Kim; Dae Chul Suh
Journal:  Neurointervention       Date:  2011-08-31

4.  Combined Transradial and Transfemoral Approach With Ostial Vertebral Balloon Protection for the Treatment of Patients With Subclavian Steal Syndrome.

Authors:  Rami Fakih; Sudeepta Dandapat; Alan Mendez-Ruiz; Aldo A Mendez; Mudassir Farooqui; Cynthia Zevallos; Darko Quispe Orozco; David Hasan; James Rossen; Edgar A Samaniego; Colin Derdeyn; Santiago Ortega-Gutierrez
Journal:  Front Neurol       Date:  2020-10-22       Impact factor: 4.003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.